EECP Recieves Class IIa Recommendation in European Society of Cardiology Guidelines for Management of Stable Coronary Artery Disease
EECP (Enhanced External Counterpulsation Therapy) is given a lla Class of Recommendation in the 2013 European Society of Cardiology (ESC) Guidelines on the Management of Stable Coronary Artery Disease (SCAD). The guidelines were released during ESC’s annual meeting which took place from August 31 to September 3, 2013 in Amsterdam, the Netherlands.
The Class IIa signifies high level of evidence in favor that physicians should consider EECP Therapy as a treatment option for patients suffering from chronic stable angina. The American College of Cardiology Foundation and The American Heart Association (ACCF/AHA) Task Force on Practice Guidelines retained the same IIb Class of Recommendation rating issued in the ACC/AHA 2002 Guideline Update for the Management of Patients with Chronic Stable Angina. The approval with the ESC represents a positive step towards upgrading EECP Therapy’s level of recommendation to lla in its future guideline with the ACC / AHA Guidelines. .
EECP is a safe & effective non invasive solution proven to reduce re-hospitalizations and emergency room visits. Proponents of EECP Therapy believe this treatment should be available to a much wider patient base as it is a much safer, lower cost solution that provides substantial benefits to many medical ailments beyond Coronary Artery Disease.